首页>Cancer Chemotherapy and Pharmacology>A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
作者单位：Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul[1]Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil[2]Department of General Surgery, Gachon University Gil Hospital, Incheon, South Korea[3]
换一批
